Abstract: The present invention provides improved process for preparation of revaprazan hydrochloride (I) comprising reaction of 1-methyl-1,2,3,4-tetrahydroisoquinoline (III) withcompound (VII)wherein R is a good leaving group selected from F, Cl, Br, I, in presence of phase transfer catalyst and solvent to give revaprazan (VI) and followed by treatment with hydrochloride acid.
SEE ATTACHED
| # | Name | Date |
|---|---|---|
| 1 | 1171-KOL-2012-(29-11-2012)-FORM-1.pdf | 2012-11-29 |
| 1 | 1171-KOL-2012-AbandonedLetter.pdf | 2019-07-05 |
| 2 | 1171-KOL-2012-FER.pdf | 2018-12-19 |
| 2 | 1171-KOL-2012-(29-11-2012)-CORRESPONDENCE.pdf | 2012-11-29 |
| 3 | Form 18 [24-09-2016(online)].pdf | 2016-09-24 |
| 3 | 1171-KOL-2012-(17-10-2013)-CORRESPONDENCE.pdf | 2013-10-17 |
| 4 | 1171-KOL-2012-(17-10-2013)-ANNEXURE TO FORM 3.pdf | 2013-10-17 |
| 4 | 1171-KOL-2012 ABSTRACT.pdf | 2013-10-25 |
| 5 | 1171-KOL-2012 SPECIFICATION.pdf | 2013-10-25 |
| 5 | 1171-KOL-2012 CLAIMS.pdf | 2013-10-25 |
| 6 | 1171-KOL-2012 PA.pdf | 2013-10-25 |
| 6 | 1171-KOL-2012 DESCRIPTION COMPLETE.pdf | 2013-10-25 |
| 7 | 1171-KOL-2012 FORM-3.pdf | 2013-10-25 |
| 7 | 1171-KOL-2012 DRAWINGS.pdf | 2013-10-25 |
| 8 | 1171-KOL-2012 FORM-2.pdf | 2013-10-25 |
| 9 | 1171-KOL-2012 FORM-3.pdf | 2013-10-25 |
| 9 | 1171-KOL-2012 DRAWINGS.pdf | 2013-10-25 |
| 10 | 1171-KOL-2012 DESCRIPTION COMPLETE.pdf | 2013-10-25 |
| 10 | 1171-KOL-2012 PA.pdf | 2013-10-25 |
| 11 | 1171-KOL-2012 SPECIFICATION.pdf | 2013-10-25 |
| 11 | 1171-KOL-2012 CLAIMS.pdf | 2013-10-25 |
| 12 | 1171-KOL-2012-(17-10-2013)-ANNEXURE TO FORM 3.pdf | 2013-10-17 |
| 12 | 1171-KOL-2012 ABSTRACT.pdf | 2013-10-25 |
| 13 | Form 18 [24-09-2016(online)].pdf | 2016-09-24 |
| 13 | 1171-KOL-2012-(17-10-2013)-CORRESPONDENCE.pdf | 2013-10-17 |
| 14 | 1171-KOL-2012-FER.pdf | 2018-12-19 |
| 14 | 1171-KOL-2012-(29-11-2012)-CORRESPONDENCE.pdf | 2012-11-29 |
| 15 | 1171-KOL-2012-AbandonedLetter.pdf | 2019-07-05 |
| 15 | 1171-KOL-2012-(29-11-2012)-FORM-1.pdf | 2012-11-29 |
| 1 | 1171_14-12-2018.pdf |